Literature DB >> 25250271

Reflux esophagitis in war-related sulfur mustard lung disease.

Nader Roushan1, Fateme Zali2, Hamidreza Abtahi3, Mehrnaz Asadi4, Reza Taslimi5, Najme Aletaha6.   

Abstract

UNLABELLED: Background Sulfur mustard (SM) has acute and chronic effects on skin and mucosal surfaces. The aim of the study was to evaluate the frequency of esophagitis in a historical cohort of veterans who had been exposed to SM in Iran-Iraq war nearly 25 years ago.
METHODS: One hundred two veterans with dyspepsia and/or heartburn underwent esophago-gastroduodenoscopy. Of them, 52 cases had been exposed to SM and had chronic mustard lung disease. Controls included 50 veterans without SM exposure. Esophagitis was defined according to standard criteria.
RESULTS: 81.6% of cases and 70.6% of controls had heart burn and/or regurgitation (p= 0.224). Esophagitis was seen in 40% of cases and 26.5% of controls (p= 0.155).
CONCLUSION: Based on our findings, SM exposure seems not to be associated with increased esophagitis.

Entities:  

Keywords:  Esophagitis; Gastroesophageal reflux; Sulfur mustard

Year:  2014        PMID: 25250271      PMCID: PMC4153531     

Source DB:  PubMed          Journal:  Med J Islam Repub Iran        ISSN: 1016-1430


Introduction

Sulfur mustard (SM) is an alkylating agent that was used as a chemical weapon in wars including World War I and Iran-Iraq War (1980–1988). Acute SM exposure causes skin and mucosal injuries. Symptoms include skin blister, rhinorrhea, cough, dyspnea, eye pain and redness, anorexia, nausea and vomiting. In addition, SM causes chronic sequele in upper and lower respiratory tracts, eyes and hematologic elements among others; the best recognized is bronchiolitis obliterans (BO) of the lung (1-3). Gastroesophageal reflux disease (GERD) is defined as troublesome symptoms or complications which develop from reflux of stomach contents to the esophagus. Typical symptoms include heartburn and regurgitation; other symptoms may be chest pain, cough, hoarseness, bitter taste in mouth, etc. Complications of GERD are stricture, Barrett’s epithelium and adenocarcinoma of esophagus (4-6). GERD is among the most common disorders seen by primary care physicians and also by gastroenterologists (4,7,8). Its prevalence is reported between 10-40% and is increasing in recent decades in both developed and developing countries (7-11). Presumptive diagnosis of GERD can be done by typical history of heartburn and/or regurgitation. Esophagogastroduodenoscopy (EGD) is only required when alarm symptoms is present or in screening of high risk patients such as older males with chronic GERD symptoms (4, 7, 8). Association of GERD and pulmonary diseases such as asthma, cystic fibrosis, and idiopathic pulmonary fibrosis has been reported (12-16). Most importantly, GERD has been linked to BO, lung failure and decreased survival in the lung transplant recipients (17). Ghanei et al. reported increased frequency of esophageal erythema in war-related BO patients (18). This finding is not widely accepted in current classification systems for esophagitis (19, 20). The aim of this study is to assess the frequency of endoscopic esophagitis in SM exposed victims.

Methods

The cases were SM victims from Iran-Iraq war with GERD symptoms and/or dyspepsia, which visited in the Sasan Hospital, a referral center for management of SM casualties in Tehran, from November 2011 to April 2013. All of them had documented exposure to SM nearly 25 years ago in Iraq-Iran War and suffered from chronic mustard lung diseases, mostly BO. Controls were among the same veterans that were not exposed to SM, no history of lung diseases and were referred for EGD for evaluation of their GERD and/or dyspepsia. Before EGD, demographic data and reflux symptoms were recorded according to the questionnaire used in the only GERD cohort in Iran, Prospective Acid Reflux Study of Iran (PARSI) (9). Proton pump inhibitors (PPI) and histamine-2 receptor blockers (H2RB) were discontinued for 4 weeks before EGD, if patients took it. Esophagitis was defined according to the Los Angeles classification (Table 1) (19).
Table 1

Los Angeles endoscopic grading system for esophagitis

Grade A≥1 mucosal breaks confined to folds, ≤5 mm
Grade B≥1 mucosal breaks >5 mm confined to folds but not continuous between tops of mucosal folds
Grade CMucosal breaks continuous between tops of two or more mucosal folds but not circumferential
Grade DCircumferential mucosal break
The study was approved by the Tehran University of Medical Sciences Ethics committee and informed consent was obtained from the patients.

Statistical methods

Data analysis was done by the SPSS software, version 16.0. Mean and standard deviation (SD) were used for showing the numeric variables and percentages were used for the categorical variables. T-test was used for assessing the relationship between numeric variables with categorical variables. Chi square test was used for assessing the relationships among categorical variables. p<0.05 was considered statistically significant.

Results

Fifty two cases and 50 controls underwent EGD. Mean age for the cases and the controls were 47.5±5.6 years and 46.8± 5 years, respectively. There was no significant difference (p=0.49) in age between the two groups. Additionally, educational status was not significantly different between two groups (p=0.9). There was no meaningful difference regarding the frequency of heartburn and regurgitation between the two groups. No difference was also found in the use of PPI and H2RB. Table 2 shows the above mentioned findings in cases and controls.
Table 2

Sulfur mustard (SM) victims and controls data about their gastroesophageal reflux disease

VariableSM Victims (n=52) percentControls (n=50) Percentp-value
Reflux † ≥1 episode/week81.670.60.224
Dysphagia223.90.007
Odynophagia1017.60.007
Vomiting213.70.060
PPI use ‡4424.50.113
H2RB use §1422.40.113
Smoking1233.30.01
Esophagitis4026.50.155

† reflux means heart burn and/or regurgitation, ‡ PPI means proton pump inhibitor drugs, §H2RB means histamine 2 receptor blocker drugs

† reflux means heart burn and/or regurgitation, ‡ PPI means proton pump inhibitor drugs, §H2RB means histamine 2 receptor blocker drugs Forty percent of cases and 26.5% of controls had esophagitis, but this was not statistically significant (p=0.15). No significant difference was also detected among the grades of esophagitis (A, B, C, D) (p=0.276).

Discussion

Our study didn’t show any difference in the frequency of esophagitis between SM victims and controls. Frequency of esophagitis in our cases and controls was also comparable with a previous report of esophagitis in an endoscopy survey in Iran done by Saidi et al. He found a prevalence of 37% for esophagitis compared with 26.5% of our controls and 40% of our cases (21). Ghanei et al. in a case control study of veterans who had been exposed to SM in Iran-Iraq War showed a prevalence of 70% endoscopic esophagitis as compared to 42.7% of controls without exposure to SM; both cases and controls were veterans with GERD and chronic cough (18). He used a classification that considered erythema or friability as grade 1 of esophagitis and erosion as grade 2. Currently, only two classification systems are widely accepted worldwide for esophagitis: Savary-Miller and Lose Angeles; both require erosion or mucosal break as the least criteria for esophagitis (19, 20). The difference between cases and controls in Ghanei study was grade 1 patients (62 cases vs. 15 controls); grade 2 or more that requires erosion was not different between the two groups (1 case vs. 2 controls). As pathological examination of distal esophagus is not useful in diagnosis of GERD and not recommended by current literature, we did not perform it (7, 22).

Conclusion

It appears that SM did not have chronic effect on esophagus and specifically did not increase esophagitis.A larger study is necessary to evaluate the relation of GERD and Mustard lung disease.
  21 in total

Review 1.  Gastro-oesophageal reflux disease.

Authors:  Paul Moayyedi; Nicholas J Talley
Journal:  Lancet       Date:  2006-06-24       Impact factor: 79.321

2.  Delayed ocular, pulmonary, and cutaneous complications of mustards in patients in the city of Sardasht, Iran.

Authors:  Mohammad Ghassemi-Broumand; Jafar Aslani; Seyed-Naser Emadi
Journal:  Cutan Ocul Toxicol       Date:  2008       Impact factor: 1.820

Review 3.  Medical aspects of sulphur mustard poisoning.

Authors:  Kai Kehe; Ladislaus Szinicz
Journal:  Toxicology       Date:  2005-08-03       Impact factor: 4.221

4.  Diffuse pulmonary fibrosis and hiatus hernia.

Authors:  J E Pearson; R S Wilson
Journal:  Thorax       Date:  1971-05       Impact factor: 9.139

5.  Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study.

Authors:  Michael Camilleri; Dominique Dubois; Bernard Coulie; Michael Jones; Peter J Kahrilas; Anne M Rentz; Amnon Sonnenberg; Vincenzo Stanghellini; Walter F Stewart; Jan Tack; Nicholas J Talley; William Whitehead; Dennis A Revicki
Journal:  Clin Gastroenterol Hepatol       Date:  2005-06       Impact factor: 11.382

6.  Is there a set of histologic changes that are invariably reflux associated?

Authors:  Kaiyo Takubo; Naoko Honma; Gopi Aryal; Motoji Sawabe; Tomio Arai; Yasuo Tanaka; Ken-ichi Mafune; Katsuhiko Iwakiri
Journal:  Arch Pathol Lab Med       Date:  2005-02       Impact factor: 5.534

7.  Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis.

Authors:  R W Tobin; C E Pope; C A Pellegrini; M J Emond; J Sillery; G Raghu
Journal:  Am J Respir Crit Care Med       Date:  1998-12       Impact factor: 21.405

8.  Endoscopic esophageal cancer survey in the western part of the Caspian Littoral.

Authors:  F Saidi; R Malekzadeh; M Sotoudeh; M H Derakhshan; M J Farahvash; A Yazdanbod; Sh Merat; J Mikaeli; R Sotoudehmanesh; S Nasseri-Moghadam; A Majidpour; S Arshi; B Abedi-Ardakani; A Yoonessi; F Sadr; A Sepehr; D Fleischer; S Fahimi
Journal:  Dis Esophagus       Date:  2002       Impact factor: 3.429

Review 9.  Body weight, lifestyle, dietary habits and gastroesophageal reflux disease.

Authors:  Davide Festi; Eleonora Scaioli; Fabio Baldi; Amanda Vestito; Francesca Pasqui; Anna Rita Di Biase; Antonio Colecchia
Journal:  World J Gastroenterol       Date:  2009-04-14       Impact factor: 5.742

10.  Prospective Acid Reflux Study of Iran (PARSI): methodology and study design.

Authors:  Siavosh Nasseri-Moghaddam; Hadi Razjouyan; Seyed Maysam Alimohamadi; Mansoureh Mamarabadi; Mohamad-Hamed Ghotbi; Pardis Mostajabi; Amir-Ali Sohrabpour; Masoud Sotoudeh; Behnoush Abedi; Azadeh Mofid; Mehdi Nouraie; Shahnaz Tofangchiha; Reza Malekzadeh
Journal:  BMC Gastroenterol       Date:  2007-11-20       Impact factor: 3.067

View more
  1 in total

1.  Gastrointestinal problems in modern wars: clinical features and possible mechanisms.

Authors:  Wei-Feng Wang; Xiao-Xu Guo; Yun-Sheng Yang
Journal:  Mil Med Res       Date:  2015-06-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.